Patrick Marcellin
- Hepatology top 0.01%
- Hepatitis C virus research 546
- Liver Disease and Transplantation 32
- Hepatitis Viruses Studies and Epidemiology 32
- Liver Diseases and Immunity 32
- Epidemiology top 0.01%
- Hepatitis B Virus Studies 411
- Liver Disease Diagnosis and Treatment 387
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 41
- Rheumatology top 0.2%
- Systemic Lupus Erythematosus Research 63
- Virology top 1%
- Co-authors
- Tarik AsselahNathalie BoyerVictor de LédinghenDominique VallaMichel BeaugrandZachary GoodmanStephanos J. HadziyannisMarianne Ziol
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Patrick Marcellin
616 papers receiving 37.6k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Hepatology 34.2k
- Epidemiology 34.3k
- Infectious Diseases 4.1k
- Rheumatology 2.0k
- Virology 486
Countries citing papers authored by Patrick Marcellin
This map shows the geographic impact of Patrick Marcellin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Marcellin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Marcellin more than expected).
Fields of papers citing papers by Patrick Marcellin
This network shows the impact of papers produced by Patrick Marcellin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Marcellin. The network helps show where Patrick Marcellin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick Marcellin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 17 | |
| 2 | 2019 | 15 | |
| 3 | Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB) | 2015 | 1 |
| 4 | 2014 | 29 | |
| 5 | 2014 | 23 | |
| 6 | 2014 | 9 | |
| 7 | 2014 | 7 | |
| 8 | 2013 | 8 | |
| 9 | 2012 | 79 | |
| 10 | 2011 | 6 | |
| 11 | 2011 | 49 | |
| 12 | 2010 | 0 | |
| 13 | 2010 | 1 | |
| 14 | 2010 | 12 | |
| 15 | 2008 | 0 | |
| 16 | 2007 | 1 | |
| 17 | 2004 | 64 | |
| 18 | 2003 | 1 | |
| 19 | [Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]. | 1998 | 2 |
| 20 | [Natural history of hepatitis C virus infection]. | 1995 | 3 |
About Patrick Marcellin
Patrick Marcellin is a scholar working on Hepatology, Epidemiology and Rheumatology, having authored 635 papers that have together received 38.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (546 papers), Hepatitis B Virus Studies (411 papers), Liver Disease Diagnosis and Treatment (387 papers), Systemic Lupus Erythematosus Research (63 papers), HIV/AIDS drug development and treatment (41 papers), Liver Disease and Transplantation (32 papers), Hepatitis Viruses Studies and Epidemiology (32 papers) and Liver Diseases and Immunity (32 papers). The work is most often cited by research in Hepatology (34.2k citations), Epidemiology (34.3k citations) and Infectious Diseases (4.1k citations). Patrick Marcellin has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Tarik Asselah, Nathalie Boyer, Victor de Lédinghen, Dominique Valla, Michel Beaugrand, Zachary Goodman, Stephanos J. Hadziyannis, Marianne Ziol, Claude Degott and Pierre Bédossa. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Liver International and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.